Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Christianity | 1 | 2023 | 3 | 0.780 |
Why?
|
| Islam | 1 | 2023 | 16 | 0.770 |
Why?
|
| Cushing Syndrome | 1 | 2018 | 23 | 0.550 |
Why?
|
| Dexamethasone | 1 | 2018 | 30 | 0.550 |
Why?
|
| Drug Resistance | 2 | 2015 | 16 | 0.540 |
Why?
|
| Hyperglycemia | 1 | 2015 | 27 | 0.460 |
Why?
|
| Drug Monitoring | 1 | 2015 | 16 | 0.460 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 39 | 0.440 |
Why?
|
| Insulin | 1 | 2015 | 146 | 0.420 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 165 | 0.400 |
Why?
|
| Tuberculosis, Hepatic | 1 | 2012 | 1 | 0.380 |
Why?
|
| Hypertension, Portal | 1 | 2012 | 3 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 279 | 0.360 |
Why?
|
| Humans | 14 | 2023 | 6794 | 0.350 |
Why?
|
| Refugees | 3 | 2015 | 18 | 0.320 |
Why?
|
| Female | 10 | 2021 | 4060 | 0.290 |
Why?
|
| Adolescent | 6 | 2018 | 869 | 0.270 |
Why?
|
| Middle Aged | 6 | 2021 | 2108 | 0.250 |
Why?
|
| Kidney Diseases | 3 | 2014 | 121 | 0.240 |
Why?
|
| Male | 8 | 2018 | 3671 | 0.220 |
Why?
|
| Judaism | 1 | 2023 | 1 | 0.200 |
Why?
|
| Retrospective Studies | 5 | 2021 | 681 | 0.190 |
Why?
|
| Psychiatry | 1 | 2023 | 10 | 0.190 |
Why?
|
| Antibodies, Bispecific | 1 | 2021 | 3 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 7 | 0.180 |
Why?
|
| Janus Kinases | 1 | 2021 | 3 | 0.170 |
Why?
|
| Primary Myelofibrosis | 1 | 2021 | 3 | 0.170 |
Why?
|
| Pyrazoles | 1 | 2021 | 11 | 0.170 |
Why?
|
| Referral and Consultation | 3 | 2023 | 61 | 0.170 |
Why?
|
| Disease Progression | 1 | 2021 | 170 | 0.170 |
Why?
|
| Nephrotic Syndrome | 2 | 2011 | 5 | 0.170 |
Why?
|
| Young Adult | 3 | 2018 | 567 | 0.160 |
Why?
|
| Adult | 4 | 2018 | 2113 | 0.150 |
Why?
|
| Hydrocortisone | 1 | 2018 | 33 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 155 | 0.140 |
Why?
|
| Medical Records | 1 | 2015 | 23 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 50 | 0.110 |
Why?
|
| Urban Health Services | 1 | 2015 | 17 | 0.110 |
Why?
|
| Weight Gain | 1 | 2015 | 28 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 25 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 84 | 0.110 |
Why?
|
| Anesthesiology | 1 | 2015 | 3 | 0.110 |
Why?
|
| Anesthesia | 1 | 2015 | 8 | 0.110 |
Why?
|
| Glycated Hemoglobin A | 1 | 2015 | 65 | 0.110 |
Why?
|
| Physician's Role | 1 | 2015 | 15 | 0.110 |
Why?
|
| Neoplasms | 1 | 2015 | 92 | 0.110 |
Why?
|
| Los Angeles | 1 | 2015 | 321 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2015 | 188 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 153 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 79 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 64 | 0.090 |
Why?
|
| Amyloidosis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Neutropenia | 1 | 2011 | 4 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2011 | 12 | 0.090 |
Why?
|
| Child, Preschool | 4 | 2014 | 258 | 0.080 |
Why?
|
| Afghanistan | 3 | 2015 | 10 | 0.080 |
Why?
|
| Child | 4 | 2014 | 524 | 0.080 |
Why?
|
| Urethra | 1 | 2009 | 7 | 0.080 |
Why?
|
| Urination Disorders | 1 | 2009 | 6 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2009 | 65 | 0.080 |
Why?
|
| Iran | 3 | 2015 | 68 | 0.070 |
Why?
|
| Infant | 3 | 2014 | 187 | 0.070 |
Why?
|
| Recurrence | 2 | 2021 | 55 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 420 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 8 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2023 | 23 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 506 | 0.050 |
Why?
|
| Nitriles | 1 | 2021 | 13 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2021 | 17 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2009 | 95 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2015 | 3 | 0.030 |
Why?
|
| Minority Health | 1 | 2015 | 6 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 26 | 0.030 |
Why?
|
| Fear | 1 | 2015 | 8 | 0.030 |
Why?
|
| Urban Health | 1 | 2015 | 20 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 29 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 28 | 0.030 |
Why?
|
| Trust | 1 | 2015 | 33 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2015 | 51 | 0.030 |
Why?
|
| California | 1 | 2015 | 230 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 199 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 280 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2012 | 19 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 45 | 0.020 |
Why?
|
| Health Status | 1 | 2012 | 83 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 155 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 28 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 31 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 98 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 21 | 0.020 |
Why?
|
| Creatinine | 1 | 2009 | 48 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 193 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 285 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 214 | 0.020 |
Why?
|
| Aged | 1 | 2012 | 1539 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2009 | 500 | 0.020 |
Why?
|
| Risk Factors | 1 | 2009 | 767 | 0.020 |
Why?
|